• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Tandem Diabetes Care CCO is set to resign

August 21, 2023 By Sean Whooley

Tandem Diabetes Care updated logoTandem Diabetes Care (Nasdaq:TNDM) filed an SEC Form 8-K announcing its chief commercial officer’s intent to resign.

Brian B. Hansen, EVP and CCO, notified the company of his decision to resign on Aug. 17. His resignation goes into effect on Dec. 31, 2023.

In connection with Hansen’s resignation, he and the automated insulin delivery technology maker entered into a separation agreement. Under this agreement, dated Aug. 18, Hansen remains employed until June 28, 2024. However, he will be on administrative leave after the Dec. 31, 2023, effective date.

Along with receiving his base salary through the separation date, Hansen remains entitled to a cash bonus as determined by the company. He also stands to receive COBRA premiums for up to six months following the effective date. Tandem said that equity awards by held by Hansen continue to vest through the separation date, too.

Hansen became EVP and CCO at Tandem Diabetes Care in February 2016. Before joining the company, he served as chief commercial officer at Adaptive Biotechnologies, starting in September 2014. Prior to that, he was head of commercial, sales and marketing at Novartis’ Genoptix.

From December 2005 to February 2013, Hansen held a number of roles of increasing responsibility at Gen-Probe. That stint culminated in his serving as SVP, global sales and services from January 2012 to February 2013.

Tandem Diabetes Care develops automated insulin delivery products, including its flagship t:slim X2 pump with Control-IQ technology. The company last month won FDA clearance for its Mobi automated insulin delivery system, which is less than half the size of the t:slim X2.

The company also recently announced a new, limited-time offer for its Tandem Choice technology access program. This program now provides new and renewing, eligible users of its t:slim X2 pump a pathway to new offerings like Mobi.

 

Next: The biggest medtech personnel moves so far in 2023>>

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Personnel, Technology Tagged With: Personnel Moves, Tandem Diabetes Care

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS